Gujarat Terce Laboratories Ltd Stock Price Today (NSE: GUJTERC)
Fundamental Score
Gujarat Terce Laboratories Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Gujarat Terce Laboratories Ltd share price today is ₹42.23, up +0.00% on NSE/BSE as of 18 February 2026. Gujarat Terce Laboratories Ltd (GUJTERC) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹34.63 (Cr). The 52-week high for GUJTERC share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -14.57% and a debt-to-equity ratio of 0.08.
Gujarat Terce Laboratories Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Gujarat Terce Laboratories Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Gujarat Terce Laboratories Share Price
The pharmaceutical sector is currently experiencing a period of consolidation, with smaller players needing to demonstrate exceptional operational efficiency to thrive. This analysis focuses on the financial stability of Gujarat Terce Laboratories Ltd, specifically examining the factors influencing its share price. At ₹44.25, the Gujarat Terce Laboratories share price reflects market sentiment amidst broader industry dynamics. This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
One immediate observation is the absence of a Price-to-Earnings (PE) ratio. This often indicates that the company is currently unprofitable or has fluctuating earnings, requiring further investigation into its profitability drivers and future earnings potential. A high Return on Capital Employed (ROCE) of 41.41% is, however, a positive indicator. ROCE reflects how efficiently a company generates profits from its capital employed. In Gujarat Terce Laboratories' case, this suggests the company is effectively utilizing its resources, potentially creating a strong competitive advantage. This impressive ROCE could be a crucial element in building a significant moat for the company, allowing it to sustain profitability even amidst competitive pressures.
Comparing Gujarat Terce Laboratories Ltd to its peers is crucial.
Mankind Pharma Ltd, for example, is known for its experienced and well-regarded management team. A similar assessment of Gujarat Terce Laboratories' leadership and strategic vision is necessary to gauge its long-term prospects. While Mankind Pharma Ltd may have a higher valuation, Gujarat Terce Laboratories' ROCE indicates a strong ability to generate returns. Other peers like Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd also offer benchmarks for assessing Gujarat Terce Laboratories' performance in terms of revenue growth, profitability margins, and debt management.In conclusion, while the absence of a PE ratio presents a question mark, the high ROCE of 41.41% suggests significant operational efficiency. A thorough assessment of management quality, competitive landscape, and sustained profitability is necessary to understand the long-term prospects for the Gujarat Terce Laboratories share price. Further research into the underlying factors driving the ROCE is vital to ascertain its sustainability.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Gujarat Terce Laboratories Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GUJTERC across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Excellent ROCE Performance (41.41%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (14.52x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Below-Average Return on Equity (-14.57%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Margin Pressure Concerns (0.72%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Gujarat Terce Laboratories Ltd Financial Statements
Comprehensive financial data for Gujarat Terce Laboratories Ltd including income statement, balance sheet and cash flow
About GUJTERC (Gujarat Terce Laboratories Ltd)
Gujarat Terce Laboratories Ltd (GUJTERC) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹34.63 (Cr). Gujarat Terce Laboratories Ltd has delivered a Return on Equity (ROE) of -14.57% and a ROCE of 41.41%. The debt-to-equity ratio stands at 0.08, reflecting the company's capital structure. Investors tracking GUJTERC share price can monitor key metrics including P/E ratio, promoter holding of 37.03%, and quarterly earnings growth.
Company Details
Key Leadership
GUJTERC Share Price: Frequently Asked Questions
What is the current share price of Gujarat Terce Laboratories Ltd (GUJTERC)?
As of 18 Feb 2026, 10:37 am IST, Gujarat Terce Laboratories Ltd share price is ₹42.23. The GUJTERC stock has a market capitalisation of ₹34.63 (Cr) on NSE/BSE.
Is GUJTERC share price Overvalued or Undervalued?
GUJTERC share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the Gujarat Terce Laboratories Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of GUJTERC share price?
The 52-week high of GUJTERC share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Gujarat Terce Laboratories Ltd share price?
Key factors influencing GUJTERC share price include quarterly earnings growth (Sales Growth: -2.78%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Gujarat Terce Laboratories Ltd a good stock for long-term investment?
Gujarat Terce Laboratories Ltd shows a 5-year Profit Growth of N/A% and an ROE of -14.57%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.08 before investing in GUJTERC shares.
How does Gujarat Terce Laboratories Ltd compare with its industry peers?
Gujarat Terce Laboratories Ltd competes with major peers in the Pharmaceuticals. Investors should compare GUJTERC share price P/E of 0.00x and ROE of -14.57% against the industry averages to determine competitive standing.
What is the P/E ratio of GUJTERC and what does it mean?
GUJTERC share price has a P/E ratio of N/Ax compared to the industry average of 31.77x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is GUJTERC performing according to Bull Run's analysis?
GUJTERC has a Bull Run fundamental score of 8.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does GUJTERC belong to?
GUJTERC operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Gujarat Terce Laboratories Ltd share price.
What is Return on Equity (ROE) and why is it important for GUJTERC?
GUJTERC has an ROE of -14.57%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Gujarat Terce Laboratories Ltd generates profits from shareholders capital.
How is GUJTERC debt-to-equity ratio and what does it indicate?
GUJTERC has a debt-to-equity ratio of 0.08, which indicates conservative financing with low financial risk.
What is GUJTERC dividend yield and is it a good dividend stock?
GUJTERC offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Gujarat Terce Laboratories Ltd shares.
How has GUJTERC share price grown over the past 5 years?
GUJTERC has achieved 5-year growth rates of: Sales Growth 5.98%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in GUJTERC and why does it matter?
Promoters hold 37.03% of GUJTERC shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Gujarat Terce Laboratories Ltd.
What is GUJTERC market capitalisation category?
GUJTERC has a market capitalisation of ₹35 crores, placing it in the Small-cap category.
How volatile is GUJTERC stock?
GUJTERC has a beta of N/A. A beta > 1 suggests the Gujarat Terce Laboratories Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is GUJTERC operating profit margin trend?
GUJTERC has a 5-year average Operating Profit Margin (OPM) of 0.72%, indicating the company's operational efficiency.
How is GUJTERC quarterly performance?
Recent quarterly performance shows Gujarat Terce Laboratories Ltd YoY Sales Growth of -2.78% and YoY Profit Growth of -5.41%.
What is the institutional holding pattern in GUJTERC?
GUJTERC has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Gujarat Terce Laboratories Ltd stock.